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Background:  Nucleoside monophosphate kinases (NMP kinases) catalyze the
reversible transfer of a phosphoryl group from a nucleoside triphosphate to a
nucleoside monophosphate. Among them, cytidine monophosphate kinase from
Escherichia coli has a striking particularity: it is specific for CMP, whereas in
eukaryotes a unique UMP/CMP kinase phosphorylates both CMP and UMP
with similar efficiency.
Results: The crystal structure of the CMP kinase apoenzyme from E. coli was
solved by single isomorphous replacement and refined at 1.75 Å resolution. The
structure of the enzyme in complex with CDP was determined at 2.0 Å
resolution. Like other NMP kinases, the protein contains a central parallel
β sheet, the strands of which are connected by α helices. The enzyme differs
from other NMP kinases in the presence of a 40-residue insert situated in the
NMP-binding (NMPbind) domain. This insert contains two domains: one
comprising a three-stranded antiparallel β sheet, the other comprising two
α helices.
Conclusions: Two features of the CMP kinase from E. coli have no equivalent
in other NMP kinases of known structure. Firstly, the large NMPbind insert
undergoes a CDP-induced rearrangement: its β-sheet domain moves away from
the substrate, whereas its helical domain comes closer to it in a motion likely to
improve the protection of the active site. Secondly, residues involved in CDP
recognition are conserved in CMP kinases and have no counterpart in other
NMP kinases. The structures presented here are the first of a new family of
NMP kinases specific for CMP.
Introduction
Nucleoside monophosphate kinases (NMP kinases) are
key enzymes involved in the metabolism of nucleotides.
They act specifically on the various NMPs formed in the
de novo or salvage pathways of purine or pyrimidine nucleo-
tides, by catalyzing the reversible transfer of a phosphoryl
group from a nucleoside triphosphate to an NMP [1]. As
the phosphate donor is often ATP, NMP kinases are also
called ATP:NMP phosphotransferases.
The substrate-binding domains of NMP kinases share sub-
stantial sequence similarity, and the enzymes of this family
exhibit a related three-dimensional structure. However,
the presence of insertions in regions that change confor-
mation upon substrate binding (see below) induces a
structural diversity in this family of proteins. Most NMP
kinases are specific for the base moiety of nucleotides,
but this is not a general rule: in eukaryotes, the same
enzyme phosphorylates both UMP and CMP with similar
efficiency. Because UMP kinases from bacteria have an
absolute specificity for UMP as acceptor, the existence of
at least one enzyme acting specifically on CMP was pos-
tulated many years ago. Indeed, the cmk gene encoding
CMP kinase from Escherichia coli (CMPKeco) was recently
identified by Fricke et al. [2]. In contrast to UMP kinase,
CMPKeco is not essential to E. coli survival, probably
because of the possibility of UTP interconversion pro-
ducing CTP [2]. CMPKeco reversibly phosphorylates CMP
to CDP, using ATP as its preferred phosphoryl donor,
according to the scheme:
ATP·Mg2+ + CMP ↔ ADP·Mg2+ + CDP
Although not produced in the de novo pathway, CMP
may accumulate during the synthesis of phospholipids or
from the hydrolytic cleavage of mRNA. CMPKeco can
decrease CMP levels through the production of CDP,
which will be further phosphorylated to CTP. CTP and
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dCTP are precursors of the major biological molecules
RNA, DNA and phospholipids.
CMPKeco exhibits little overall sequence similarity with
other known NMP kinases (Figure 1), except for residues
involved in substrate binding and catalysis. The enzyme is
a monomer of 227 residues and belongs to the class of long
NMP kinases, which also includes AMP kinase from E. coli
(214 residues) [3]. This is in contrast to representatives of
the short NMP kinases, which include porcine AMP kinase
(194 residues) [4], UMP kinase from Saccharomyces cerevisiae
(204 residues) [5] and GMP kinase from S. cerevisiae (186
residues) [6]. Whereas the previously described long NMP
kinases possess an insert in the so-called ‘LID’ domain situ-
ated in their C-terminal moiety, in the case of CMPKeco an
insertion occurs in its NMP-binding (NMPbind) domain,
which is situated in its N-terminal moiety.
Several crystal structures of NMP kinases are known
including those of the thymidine/thymidylate kinase from
Herpes simplex virus [7], the bacteriophage T4 deoxynucleo-
tide kinase [8] and the TMP kinase from S. cerevisiae [9].
The structures of these three enzymes are all dimeric,
although NMP kinases are generally small monomeric
proteins of ~25 kDa. AMP kinases are the best known
with structures of the enzyme determined from several
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Figure 1
Alignment of the amino acid sequence of
CMPKeco with that of CMP kinase from
Bacillus subtilis and three representative
NMP kinases of known structure. The
secondary structure assignment of
CDP–CMPKeco is shown above. The aligned
sequences are: CMPKeco (CMPK_EC); CMP
kinase from B. subtilis (CMPK_BS); UMP
kinase from yeast (UMPK_SC); the short
porcine AMP kinase (AMPK_PG); and the
long E. coli AMP kinase (AMPK_EC). The
positions of the phosphate-binding loop (P
loop), the NMPbind domain and the LID domain
of the AMP kinase from E. coli [3] are
indicated below the alignment. Sequence
alignments are the same as in [15], except for
residues Arg131–Ser150 in which structure
superposition indicated clear improvements.
Residues typical of CMP kinases that interact
with CDP are indicated by a boxed asterisk.
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Structure
organisms: pig [4], cow [10], S. cerevisiae [11] and E. coli
[3]. The structure of GMP kinase from S. cerevisiae has
also been published [6]. Concerning those NMP kinases
that are able to phosphorylate CMP, two three-dimensional
structures were solved: uridylate kinase (UMP kinase) from
yeast, which accepts either UMP, AMP (30% relative
activity of UMP) or CMP (10% relative activity of UMP)
as phosphate acceptors [5]; and UMP/CMP kinase from
the slime mold Dictyostelium discoideum [12], which exhibits
only a slight preference for CMP compared to UMP [13].
To date, no structure of a CMP-specific NMP kinase has
been described.
Table 1 shows two striking particularities of CMPKeco.
Firstly, the enzyme is very specific for cytosine-containing
NMPs; its relative activity for UMP is less than 1% of the
value for CMP. In comparison, CMP kinase from Bacillus
subtilis, which has 37% sequence identity with CMPKeco,
has a relative activity for UMP representing 10% of that
for CMP. Secondly, both CMP and dCMP are good phos-
phate acceptors for CMPKeco, with only 5% difference in
activity. In contrast, the UMP/CMP kinases from eukary-
otes phosphorylate the corresponding deoxynucleotides
with very low efficiency.
Thus, CMP kinases have a strict specificity for the base
moiety of the NMP, but no special preference for the
sugar moiety [14,15]. The structural basis for such speci-
ficity was an open question. We present here the crystal
structures of apo CMPKeco, at 1.75 Å resolution, and of the
CDP–CMPKeco complex, at 2.0 Å resolution. These struc-
tures enable us to describe the rearrangements that are
induced on CDP binding to increase the protection of the
active site, and to point out the key residues involved in
the phosphate acceptor substrate binding and specificity.
Results and discussion
Structure determination and model
The structure of recombinant CMPKeco was elucidated
by the single isomorphous replacement using anomalous
scattering (SIRAS) technique, using only one crystal of
the mercury derivative for data collection at three different
wavelengths (Table 2). Values of the Rcullis and phasing
power show the importance of anomalous data contribution
in phasing (see PCMB2 derivative). The structure was
refined to 1.75 Å resolution, with a final crystallographic
R factor of 20.5% and an R free of 25.9% [16]. The
molecular model of apo CMPKeco consists of 212 residues,
one sulfate ion and 156 water molecules. Recombinant
CMPKeco lacks Met1. Residues 2 and 180–192 are missing
from the model due to insufficient electron density. As
the sequence Glu180–Arg188 contains eight charged and
one polar residue, the disordered region is probably exposed
to the solvent.
The structure of CDP–CMPKeco was solved by molecular
replacement, using the structure of the apoenzyme as a
model, and refined to 2.0 Å resolution with a final crystal-
lographic R factor of 21.3% and an R free of 22.0%. The
bound substrate is well defined in the electron-density
map (Figure 2). The CDP–CMPKeco model consists of
residues 3–223, two sulfate ions and 106 water molecules.
The 180–192 region is no longer disordered, and can be
modeled unambiguously (mainly as an α helix) in clear
electron density. As will be described below, residues
Asp185 and Arg188 make direct polar interactions with
CDP, explaining why the region becomes ordered. A
similar case has been reported for yeast TMP kinase. In
the structure of TMP kinase with dTMP as the only
bound substrate its LID region had weak density and
lacked secondary structure, which was probably due to the
absence of ATP. However, when the structure was deter-
mined in the presence of the bound bisubstrate inhibitor
P1-(5′-adenosyl)P5-(5′-thymidyl)pentaphosphate (TP5A), the
LID region was easier to trace and formed an α helix [9].
In Figure 1, the secondary structure elements of CDP–
CMPKeco, as inferred from mainchain hydrogen-bond dis-
tances of the final model, are indicated. They are in agree-
ment with the results of the DSSP program [17].
Description of the general fold and homology with other
NMP kinases
During catalysis, NMP kinases must prevent water from
accepting the transferred phosphoryl group. This is achieved
through an induced-fit motion in the presence of sub-
strates. As a consequence, all enzymes of the NMP kinase
family for which three-dimensional structures are known
consist of three domains. The central β sheet together
with several surrounding α helices has been designated
the CORE domain, and has been used for demonstrat-
ing the motions of the remaining two domains: the LID
domain, which covers the phosphates at the active center,
and the NMPbind domain, which forms the NMP-binding
site during catalysis [18]. Long variants described up to
now contain an insert of about 25 residues in their LID
domain. This LID insert functions as an extension of the
LID domain.
Figure 3 shows the overall structure of CMPKeco when it
binds CDP. The enzyme contains a five-stranded central
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Table 1
Relative activities of CMP and UMP/CMP kinases*.
Monophosphate E. coli B. subtilis D. discoideum
nucleosides CMP kinase CMP kinase UMP/CMP kinase
CMP 100 100 100
dCMP 105 74 7
UMP 0.8 10 88
*The methods used to measure enzyme activity were as described
previously [14].
parallel β sheet (green; Figure 3), similar to that of other
NMP kinases. When aligned to the sequences of other
NMP kinases, CMPKeco contains an insert of 40 residues
in the NMPbind domain, between α3 and α6 (see Figure 1).
This large insertion is emphasized in orange and cyan in
Figure 3a, and in red in Figure 3b. A superposition based
on the five parallel β strands (β1, β2, β6, β7 and β8) of the
structure of CDP–CMPKeco with the published structure of
UMP kinase from yeast in the presence of bound ADP and
AMP [5] was made using the program O [19] (Figure 4a).
As is generally the case for NMP kinases, and as was
suggested by sequence alignments, the overall fold is con-
served. Hence we will use the three domains — CORE
(lower half in the left-hand panel of Figure 3a), LID
(upper left quarter) and NMPbind (upper right quarter) —
as a guideline for further descriptions.
The CORE domain
The central parallel β sheet is well conserved. Accord-
ingly, helices α1 and α9 from the CORE domain occupy
similar positions and orientations to those observed in
other NMP kinases. The helix α6, connecting the NMPbind
domain to the CORE domain, is slightly different in the
structures of CDP–CMPKeco and UMP kinase from yeast
(Figure 4a). One minor difference with other NMP kinases
is that no classical helical structure connects β6 and β7 in
CMPKeco. This can be ascertained, because the electron
density in this region is very clear.
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Figure 2
The electron density for CDP. Fo–Fc omit map (in cyan) calculated for
the CDP–CMPKeco complex in the absence of the CDP model. The
map was calculated with the model phases using data in the 7.0–2.0 Å
range. The contour level is at 2σ. The refined model of CDP is shown
with carbon atoms in yellow, oxygen atoms in red, nitrogen atoms in
blue and phosphorus atoms in magenta. (The figure was prepared
using the program O [19].)
Structure
Table 2
Data collection and phasing statistics*.
Data set Native 1 Native 2 PCMB1 PCMB2 PCMB3 CDP
Space group P63 P63 P63 P63 P63 P41212
Cell dimensions (Å)
a = b 82.32 82.72 82.63 82.69 82.67 77.27
c 60.68 61.08 60.40 60.66 60.65 81.23
Wavelength (Å) 1.542 0.970 1.542 1.006 1.012 0.975
Source R-axis DW32 R-axis D2AM D2AM DW32
Data reduction Mosflm Denzo Mosflm Mosflm Mosflm Denzo
Resolution (Å) 15–1.92 30–1.75 15–2.1 15–2.7 15–2.7 30–2.0
Observed reflections 93,930 185,661 68,514 21,490 21,627 286,435
Unique reflections 17,782 23,804 13,710 6366 6347 17,252
Completeness (%)
(overall/last shell) 99.6/99.7 98.8/99.6 99.6/99.2 99.4/97.2 97.0/100 98.4/95.9
Ι/σ
(overall/last shell) 16.1/5.3 22.9/3.6 4.5/3.0 15.1/9.6 15.1/10.2 25.7/3.0
Rsym† (%)
(overall/last shell) 3.1/13.7 6.0/39.5 9.7/22.7 3.6/7.8 3.6/7.1 5.0/42.5
f′′(e–) 7.68 10.1 3.92
Riso‡ 0.246 0.210 0.210
Rcullis§
(isomorphous/anomalous) 0.62/0.84 0.56/0.61 0.57
Phasing power#
(isomorphous/anomalous) 2.7/1.6 3.2/3.4 3.1
*Calculated using native 1 data set. †Rsym = ΣhΣi |I(h,i)–<I(h)>|/ΣhΣi
I(h,i), where I(h,i) is the intensity value of the ith measurement of h and
<I(h)> is the corresponding mean value of I(h) for all i measurements.
‡Riso = Σ|FPH–FP| / ΣFP, where FPH and FP are the derivative and the
native structure-factor amplitudes, respectively.
§Rcullis = Σ||FPH–FP|–FH(calc)| / Σ|FPH–FP|, where FH(calc) is the
calculated heavy-atom structure factor (no anomalous value for
PCMB3). #Phasing power is the root mean square (rms) isomorphous
difference divided by the rms residual lack of closure (no anomalous
value for PCMB3).
The LID domain
Helices α7 and α8 are very like those of other NMP kinases.
The LID of CDP–CMPKeco is in a more open conformation
than that of UMP kinase from yeast with bound ADP in the
ATP site [5]. This is consistent with the absence of bound
substrate in the ATP site of CDP–CMPKeco.
The NMPbind domain and its Leu63–Gln102 insert: an
unprecedented structural feature among NMP kinases
In contrast to the two domains described above, important
differences can be identified in the NMPbind domain (see
upper right part of Figure 4a).
Borders of the insert
Whereas helices α2 and α6, with sequences homologous to
other NMP kinases, are in similar orientations to their coun-
terparts, the non-homologous α3 helix has no superposable
equivalent. Helix α3 allows the connection of the Leu63
end of the NMPbind insert to the distant helix α2, the posi-
tion of which is similar to that in other NMP kinases.
The three-stranded β sheet of the insert
The CMPKeco insert contains a three-stranded antiparallelβ sheet (orange; Figure 3a). In the short GMP kinase from
yeast, an antiparallel β sheet is also present in the
NMPbind domain, although it is only two-stranded [6].
However, when GMP kinase and CMPKeco are super-
posed by their CORE parallel β sheets the antiparallel
β sheets of their NMPbind domains occupy very different
positions and orientations.
The helical zone of the insert
The CMPKeco insert contains two α helices, α4 and α5
(cyan; Figure 3a). The short helix α4 is ended by a 310
helix. Among the other NMP kinases, the dimeric enzyme
deoxynucleotide kinase from bacteriophage T4 also pos-
sesses a large insertion with α helices in the NMPbind
domain. However, this insertion contains five α helices
folded in a myoglobin-like manner and a small β hairpin
[8], a structure completely different to that of CMPKeco.
Therefore, the insert of CMPKeco is original in structure
and apparently not equivalent to any part of NMPbind
domains from other NMP kinases.
Induced-fit motion to protect the active site
In previously published NMP kinase structures, the LID
domain moves upon binding of the phosphoryl donor. In
Research Article  CMP kinase from Escherichia coli Briozzo et al.    1521
Figure 3
Overall structure of the CDP–CMPKeco
complex. (a) Two orthogonal views of the
protein molecule in ribbon representation.
α Helices are colored red and numbered;
β strands are in green. Secondary structure
elements in the Leu63–Gln102 insert are
shown in cyan (α helices) and orange
(β strands). (b) Stereo drawing showing the
Cα trace of CDP–CMPKeco. Every tenth
residue is represented as a ball and every
twentieth residue is numbered. The
Leu63–Gln102 insert is shown in red. The
orientation is the same as in the left-hand
panel of (a). (The figure was drawn using the
program MOLSCRIPT [36].)
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long variants presenting an insertion in this domain, the
protection of the active site is more efficient and the LID
domain movements are greater. For this reason, discus-
sions about induced-fit motions have therefore focused
mostly on the LID domain. The NMPbind domain has also
been described as undergoing motion when it binds the
phosphoryl acceptor substrate. This movement closes the
NMP-binding site, a pocket lined by three α helices [20]
(counterparts of α2, α3 and α6 of CMPKeco).
A comparative study of the structures of various NMP kinases
showed progressive transitions from an open conformation
in the ligand-free enzyme, through partially closed states
when only one of the substrates is present, to a closed
state with both substrates bound to the protein [18]. Thus,
apo CMPKeco can be considered as an open structure,
whereas the CDP–CMPKeco structure should be considered
as partially closed. Figure 4b shows a superposition of the
CMPKeco apoenzyme with the CDP–CMPKeco complex.
CDP binding induces several noticeable changes.
The LID motion
As neither the structure of apo CMPKeco nor that of
CDP–CMPKeco contain a phosphate donor substrate, the
LID domain should stay in the same position. However,
whereas the orientation and position of the N-terminal
part of helix α8 (which can be traced for both structures)
remains essentially the same, α7 is rotated. The maximum
Cα motion is observed for Glu164, which is shifted by 8 Å.
Considering the CDP-induced motion, the LID of
CMPKeco corresponds to the Leu160–Glu172 domain,
reminiscent of the short variants from other NMP kinases.
The LID domain appears in a more open conformation 
in CDP–CMPKeco than in the apoenzyme. However,
apo CMPKeco and CDP–CMPKeco crystallize in two differ-
ent space groups and there are crystal contacts for several
residues of the LID region in both structures. Therefore,
the different LID positions observed may merely be a
reflection of the different crystal-packing arrangements.
The NMPbind domain motion
The NMPbind domain of CMPKeco corresponds to the
segment Gly37–Leu113. On binding CDP, the NMPbind
domain is rotated along an axis that would be approximately
vertical in the plane of Figure 4b. As a consequence, the
three-stranded antiparallel β sheet of the Leu63–Gln102
insert, β3 to β5, moves away from the CDP site and adopts
a more open conformation. Asn75 undergoes the largest Cα
movement (9 Å); this residue is situated between β3 and
1522 Structure 1998, Vol 6 No 12
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Figure 4 
Backbone superpositions of CDP–CMPKeco. (a) A superposition of
CDP–CMPKeco with UMP kinase from yeast in the presence of ADP
and AMP [5]. The orientation is the same as in the left-hand panel of
Figure 3a. CDP–CMPKeco is shown in blue with the Leu63–Gln102
insert in cyan. UMP kinase from yeast is shown as a thinner trace in
yellow. Labels indicate the LID domain and the position of the base of
the phosphoryl donor (NTP) and acceptor (NMP) in the published
structure of UMP kinase. The helices of CDP–CMPKeco are labeled in
blue. (b) A superposition of CDP–CMPKeco with apo CMPKeco. The
orientation is the same as in (a). For clarity, in both models only those
secondary structure elements that undergo the largest motions
induced by CDP are emphasized through ribbon representation, that
is, helix α5 and strands β5 (lower) and β6 (upper), taking into account
that these two β strands are longer in the apoenzyme. Apo CMPKeco is
shown as a thinner trace in red with the Leu63–Gln102 insert in
orange. The dashed red line connects residues 179 and 193 (labeled),
which delimit a segment where no clear density can be seen.
CDP–CMPKeco is colored as in (a). A ball-and-stick model of CDP is
shown in green.
β4. Comparison of the refined models of CMPKeco and
CDP–CMPKeco indicates that in the apoenzyme, close to
Asn75, strands β3 and β4 are longer (orange; Figure 4b).
Conversely, on binding CDP helices α5 and (to a lesser
extent) α4 move closer to the phosphate acceptor ligand
position. This closing of the helical part of the insert is
allowed by a different orientation of helix α6. As a result,
in CDP–CMPKeco the cavity for the NMP substrate is made
mainly by α2, α5 and α6, instead of the α2, α3 and α6
counterparts employed in other NMP kinases.
Therefore, the rearrangement induced by CDP to close
the phosphate acceptor cavity involves a motion of the
helical domain of the insert towards CDP, with a concomi-
tant shift of its β domain away from this substrate. The
overall induced-fit motion is thus more complicated than
that described for other NMP kinases, and cannot be
reduced to a mere closing of the NMPbind domain as a
whole onto the enzyme.
Which interactions could allow the closure of the helical part
of the Leu63–Gln102 insert over CDP?
In the CDP–CMPKeco structure, we found no direct
hydrogen bond interactions between the substrate and the
Leu63–Gln102 insert. However, two residues, Arg92 and
Ala97, interact with CDP via a water molecule (cyan;
Figure 5). The carbonyl oxygen atom of Ala97 is hydrogen
bonded to the water molecule W54, which in turn makes a
hydrogen bond with the 3′-hydroxyl of the ribose in CDP.
The Cα atom of Ala97 moves by 4.8 Å from its position in
apo CMPKeco.
A role for Arg92 in the CDP interaction is also likely; the
sidechain of this residue is clearly different in orientation
when comparing CDP–CMPKeco with the apoenzyme.
Although the Cα atom of Arg92 moves by only 2.4 Å, its
guanidinium group moves by 9.2 Å. The new orientation
of the Arg92 sidechain is stabilized by polar interactions
formed by both N atoms at the extremity of this residue:
one is connected through the water molecule W16 to an
oxygen atom of the α-phosphate of CDP (Figure 5), and
the other is located 3.3 Å from the terminal oxygen of the
Asp35 sidechain. Sequence alignments show that the
motif Ile91-Arg92-Thr93, connecting α4 to α5, is found to
be conserved in seven of the 13 CMP kinases for which
the sequences were aligned (see below); the residue
Asp35 is conserved in eight of the 13 sequences. This sug-
gests that for the helical part of the NMPbind insert, the
same CDP-induced motions observed in CMPKeco are
likely to occur in other bacterial CMP kinases.
The sulfate ion bound in the phosphate donor site
In addition to the NMP kinases, the three-dimensional
structures of a number of other mononucleotide-binding
proteins are known, for example, those of NAD(P)- or
FAD-binding proteins, protein kinases and actin [21].
CMPKeco contains the classical mononucleotide-binding
motif: a β strand (β1 for CMPKeco) and a following
α helix (α1) connected by a glycine-rich loop with the
strongly conserved fingerprint sequence Gly12-X-X-Gly-
X-Gly-Lys18. This loop forms a giant anion hole, in which
we observed a sulfate ion (S1) in both the structures of
CMPKeco and CDP–CMPKeco. S1 occupies a position
similar to that observed in the porcine [4] and bovine [20]
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Figure 5
Polar interactions with CDP. The model of
CDP is shown together with interacting atoms
of the enzyme. The orientation, chosen to
avoid overlapping of atoms, is not related to
that of Figure 4. Carbon atoms are shown in
gray, oxygen atoms in red, nitrogen atoms in
blue and phosphorus atoms in magenta.
Interactions are shown as dashed lines with
the interatomic distances given in Å. Residues
that are conserved in CMP kinases and
interact with CDP are indicated by an asterisk.
Water molecules, W54 and W16, connecting
atoms of the NMPbind insert with CDP are
shown in cyan with related distances. The
sulfur (in yellow) and oxygen atoms of the
sulfate S1 are also shown. The two water
molecules W1 and W38, situated in between
S1 and the β-phosphate of CDP, are also
shown with related interactions (in green).
(The figure was drawn with the program
MOLSCRIPT [36].)
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Structure
AMP kinases, and in yeast GMP kinase [6], which were
crystallized in the absence of phosphate donor ligand and
in the presence of ammonium sulfate. The position of the
sulfate ion corresponds to the β-phosphate of ATP [20]. In
CDP–CMPKeco, the β-phosphate of CDP interacts through
water molecules W1 and W38 (green; Figure 5) with the
S1 sulfate.
Interactions with CDP
Figure 5 shows the polar interactions of CDP with CMPKeco.
A few residues involved in CDP binding are homologous
to those of AMP kinases or UMP kinases, but most of
them are typical of CMP kinases.
Interacting residues conserved in other NMP kinases
In CMPKeco, Ser36 interacts with N4 of the amino group
from cytosine. A serine residue is also present at an
equivalent position in some AMP kinases (e.g. bovine or
yeast), or is replaced by the homologous Thr31 residue
in AMP kinase from E. coli, in which case it interacts
with the adenine of the phosphate acceptor side [3]. The
conserved residues Arg41 and Arg131 interact with phos-
phates. The sidechain of Arg131 has different orienta-
tions in CDP–CMPKeco and CMPKeco. The moving of
the arginine sidechains induced by the presence of
bound substrates is a common observation in NMP
kinases. In the published structure of UMP/CMP kinase
from D. discoideum, which was cocrystallized with CMP
[22], Arg93 (the exact counterpart of Arg131 in
CDP–CMPKeco when both structures are superposed by
their conserved central parallel β sheet) interacts with
the bound nucleotide. Aside from hydrogen-bond inter-
actions, the stacking of the nonpolar region of Arg131 on
the cytosine ring (with a 3.7 Å distance) is an original
feature of CDP–CMPKeco.
Interacting residues conserved only in CMP kinases
The opposite face of the cytosine is stacked on the aro-
matic ring of Tyr40. This stacking is allowed by the rota-
tion of the Tyr40 ring, in the presence of CDP, to a
position more parallel to the cytosine ring. Tyr40 is con-
served in CMP kinases from B. subtilis and Mycobacterium
leprae, but not in other NMP kinases (see [15] for a
sequence alignment of these CMP kinases and CMPKeco
with eight other NMP kinases). Asp185 interacts with
the 2′-hydroxyl of the ribose, yet CMPKeco does not dis-
tinguish 2′-deoxyCMP from CMP (Table 1). Arg188
(which was disordered in apo CMPKeco) and Arg110 are
hydrogen bonded to the carbonyl of the cytosine. In
addition, Arg110, the sidechain orientation of which
clearly changes in the presence of CDP, also interacts
with the N3 atom of the aromatic ring from CDP. Like
Ser36 (see above), Asp132 interacts with N4 of the amino
group from cytosine. Thus, residues typical of CMP
kinases interact mainly with the base moiety in the
CDP–CMPKeco structure.
What is the structural basis for the specificity towards
phosphate acceptor substrates?
What mechanisms exist to discriminate between pyrimi-
dine and purine nucleotides? The CDP substrate is accom-
modated in a rather narrow cavity. In addition to the short
polar interactions shown in Figure 5, Gly37, a residue con-
served in all NMP kinases, has its Cα atom located a dis-
tance of 3.7 Å to 3.8 Å from the C5 and C6 atoms of the
cytosine ring. The Cβ atom of Ala104 is situated 3.7 Å
from the 2′-oxygen of the ribose. Taking into account the
positions of the Asp132, Arg110 and Arg188 sidechains on
the opposite side of the cytosine, the cavity in which the
NMP substrate is accommodated seems too small for
purine nucleosides, thus reducing the specificity problem
to the pyrimidines. This contrasts with two other pyrimi-
dine NMP kinases, the UMP/CMP kinases from yeast [5]
and D. discoideum [12], which have a cavity to accommo-
date the phosphate acceptor that is large enough for purine
nucleotides to enter. From this point of view CMPKeco is
closer to the TMP kinase from yeast, which also has a
cavity too small for purine nucleosides [23].
What is the critical point of discrimination between CMP
and UMP? This must be related to the two structural dif-
ferences between these nucleotides. The first difference,
the fact that the N3 atom of the aromatic ring is bound to
an hydrogen in UMP and not in CMP, allows the inter-
action described above with the sidechain of Arg110, a
residue typical of CMP kinases. Interestingly, in the struc-
ture of UMP/CMP kinase from D. discoideum cocrystal-
lized with CMP [22], no polar interaction occurs between
the nitrogen of the cytosine ring and any residue of the
enzyme. The second chemical difference between the
two nucleotides is the presence in CMP of an hydrogen-
bond donor, the amino group on the base cycle, instead of
a hydrogen-bond acceptor, the carbonyl, in UMP (and
also in TMP). In the CDP–CMPKeco structure, two
residues (Ser36 and Asp132) accept a hydrogen bond
from N4. Asp132 is more typical of CMP kinase
sequences (see above) than Ser36. However, when the
two published structures of UMP/CMP kinases from
S. cerevisiae [5] and from D. discoideum [22] are superposed
with the CDP–CMPKeco structure, the position homolo-
gous to Ser36 is occupied by an alanine residue. Therefore,
no interaction comparable with that of Ser36 can occur.
Hence, in the absence of extensive site-directed mutagen-
esis experiments on CMPKeco, there are three reasonable
candidates that could explain the strong specificity of bac-
terial CMP kinases for CMP: Ser36, Arg110 and Asp132.
A new family of NMP kinases
NMP kinases have been so far classified into two fami-
lies: short NMP kinases with a short LID region, and
long NMP kinases with a long LID region that contains a
25-residue insert. Although the CMP kinases from E. coli
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and B. subtilis [14], belong to the long NMP kinase
family, they have a short LID. However, their NMPbind
domain contains a 40-residue insertion. These CMP
kinases belong to a third family of NMP kinases: the long
sequence, large insert variety. This family is not restricted
to the two members mentioned above: sequence align-
ments indicate that at least 13 published sequences of
bacterial CMP kinases contain a well-conserved insert of
around 40 residues in the same region of the NMPbind
domain as in CMPKeco. In addition to the enzymes from
E. coli and B. subtilis, the family contains CMP kinases
from Bacillus cereus, Haemophilus influenzae (two isozymes),
Mycobacterium tuberculosis, Mycobacterium leprae, Borrelia
burgdorferi, Mycoplasma genitalium, Mycoplasma pneumo-
niae, Chlamydia trachomatis, Synechocystis sp. and Aquifex
aeolicus. Amongst these, four have been extensively studied
at the biochemical level: CMP kinases from E. coli
[14,15], B. subtilis [15], M. tuberculosis (H. Munier–Lehmann,
unpublished results) and one isozyme from H. influenzae
(A-MG, unpublished results). All four enzymes have a
marked specificity for CMP compared to UMP. This
contrasts with the short UMP/CMP kinases from eukary-
otes, which accept either UMP or CMP as substrate with
comparable efficiency.
Nevertheless, the interactions with CDP described above
for the CDP–CMPKeco complex suggest that the speci-
ficity is not related to the NMPbind insert. Rather, it is
due to interacting residues typical of CMP kinase
sequences that do not belong to this insert. These
residues (emphasized by an asterisk in Figures 1 and 5)
are located in helix α2 (Tyr40), α6 (Arg110), the loop
connecting β6 to β7 (Asp132), and in the C-terminal end
of α8 (Asp185 and Arg188). All these five residues are
strikingly conserved among CMP kinases and are invari-
ant in at least 12 of the 13 aligned sequences (A-MG,
unpublished results). Whereas the NMPbind insert is the
structural characteristic of bacterial CMP kinases, residues
involved in CDP binding are disseminated all over the
sequence in different domains.
Biological implications
Nucleoside monophosphate kinases (NMP kinases) cat-
alyze the reversible phosphorylation of NMPs by nucle-
oside triphosphates, such as ATP. In eukaryotes a
unique UMP/CMP kinase phosphorylates UMP or
CMP with similar efficiency, whereas in Escherichia coli
there are two specialized enzymes: one specific for
UMP and one specific for CMP (CMP kinase; here
named CMPKeco). The structural basis for the speci-
ficity of CMP kinase was previously unknown.
In this study, two X-ray crystal structures of CMPKeco
have been determined: one of the apoenzyme (at 1.75 Å
resolution) and one of the CDP–CMPKeco complex (at
2.0 Å resolution). The overall structure of the enzyme
is similar to that of other NMP kinases and comprises
a five-stranded central parallel β sheet with α helices
connecting the β strands. The amino acid sequence of
CMPKeco contains a 40-residue insert within the NMP-
binding (NMPbind) domain. The topology of this insert
has no equivalent in previously published structures of
NMPbind inserts and comprises two α helices and a
three-stranded antiparallel β sheet. On binding to CDP,
the two α helices of the insert close upon the substrate,
whereas the β sheet moves away. Analysis of the struc-
ture has shown that the discrimination of CMP and
UMP can be achieved by three residues. These residues
make hydrogen bonds with the amino group and the
N4 atom of the cytosine ring, which distinguish CMP
from UMP. Two of these residues, Arg110 and Asp132,
are conserved in the 13 CMP kinase sequences that
were aligned in this study, but are not found in other
NMP kinases. 
Until now, NMP kinases have been classified into two
subfamilies, comprising the long and short variants. The
CMPKeco structure represents the first structure of a
third subfamily of NMP kinases: the long sequence,
large insert variants. Members of this subfamily are
defined by several typical features: the folding and
CMP-induced rearrangement of the NMPbind insert, the
interactions of residues conserved only in CMP kinases
with the phosphate acceptor substrate, and enzymatic
specificity for CMP.
The CMPKeco structures presented here could help in
the design of new drugs targeted against bacteria. Such
compounds would probably not induce side effects in the
human host organism, as eukaryotes do not possess
CMP-specific NMP kinases.
Materials and methods
Protein preparation and crystallization
Overexpression, purification and activity assays of CMPKeco were
carried out as described previously [15]. All crystals were grown at
20°C by the hanging-drop method in 50 mM Tris-HCl buffer pH 7.4,
using ammonium sulfate as a precipitant. Crystallization of native
CMPKeco was performed as described previously. The crystal system is
hexagonal with space group P63. There is one molecule per asymmet-
ric unit and the solvent content is 49% [15].
Preliminary attempts to solve the apo-CMPKeco crystal structure by
molecular replacement with known structures of NMP kinases selected
with the highest possible sequence identity (evaluated with the
BLAST program [24]) to CMPKeco failed. As the sequence contains a
single cysteine residue (Cys22), we tried to obtain mercury deriva-
tives. A useful derivative was obtained by infiltration of native CMPKeco
crystals with 1 mM parachloromercuribenzoic acid (PCMB, pur-
chased from Sigma) for 24 h. Crystals of the CDP–CMPKeco complex
were obtained by cocrystallization in a 6 µl drop containing 10 mg/ml
protein, 20 mM CDP and 0.4 M ammonium sulfate, over a pit contain-
ing 1.5 M ammonium sulfate. The crystal system is tetragonal with
space group P41212. As the unit cell contains one molecule per
asymmetric unit, the solvent content, as deduced from Matthews
coefficient [25], is 41%.
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Data collection
All data were collected at room temperature. For native crystals, a first
set of data (native 1) was collected up to 1.92 Å resolution on an
R-axis IIC image-plate detector using monochromized CuKα radiation
from a Rigaku RU-200 generator. Higher resolution data extending to
1.75 Å (native 2) were then collected on the DW32 station at the
LURE-DCI synchrotron (Orsay, France). Mercury-infiltrated crystals of
CMPKeco are very stable in the X-ray beam. Three sets of data could be
collected from a single crystal, thus avoiding nonisomorphism among
the derivative data sets: the PCMB1 data set collected on R-axis; and
two data sets collected at D2AM station at the ESRF (Grenoble,
France) with tunable synchrotron radiation. In this case two wave-
lengths were chosen near the LIII absorption edge of Hg: one with a
theoretically high anomalous f′′ value according to [26], to get a strong
anomalous signal (PCMB2 data set); another with a low anomalous f′′
(PCMB3 data set), which clearly improved anomalous phasing statis-
tics. For the crystal of the CDP–CMPKeco complex, data were collected
on the DW32 station (CDP data set). Data were processed and scaled
with the program MOSFLM [27] or in the DENZO and SCALEPACK
programs [28]. Information for all useful data collection and data pro-
cessing is given in Table 2.
Phasing
The structure of apo CMPKeco was phased via the SIRAS method. The
different sets of data were placed on the same relative scale in the
SCALEIT program from the CCP4 suite [29]. A single heavy-atom site
was refined and SIRAS phases calculated using the program SHARP
[30]. Table 2 summarizes the phasing statistics. The SIRAS phases
were improved using solvent flipping in the program SOLOMON [31]:
the figure of merit, which had an initial value of 0.589 for data up to
2.1 Å resolution, increased to 0.910, giving an interpretable map for
most of the structure. We used 40% solvent, which is appreciably
lower than the observed fraction of 49%.
The structure of the CDP–CMPKeco complex was solved by molecular
replacement at 3.0 Å resolution with the AMoRe program suite [32].
For the search model, we had to divide a partially refined model of the
native CMPKeco into two domains: a first one, MAIN, comprising residues
Ala3–Leu45, Val109–Asn170 and Leu193–Lys223; and a second
one, here named CDP-MOVE (from Ala46–Arg108) a segment which
at that time was thought to move with CDP binding. Each domain was
treated as a separate rigid-body entity. For the MAIN domain the
correct solution was the first peak in the rotation and the translation
functions. However, it was less clear for the CDP-MOVE domain: the
correct solution, which ranked first in the translation function, occupied
only the seventeenth rank in the rotation function. After rigid-body
refinement, the correlation coefficient was 0.29 with the MAIN domain
alone, and increased to 0.45 when the second CDP-MOVE domain
was also included. This resulted in an initial R factor of 45.7% for data
in the 8.0–3.0 Å range.
Model building and structure refinement
Models were built using the program O [19]; X-PLOR [33] version
3.84 was used to refine the protein model. All refinements were moni-
tored using a free R factor [16]. For the structure of the apoenzyme the
methyl-mercury site at Cys22, the unique cysteine of CMPKeco, was
used as a preliminary marker to fit the amino acid sequence. The first
SIRAS map improved with solvent flipping at 2.1 Å resolution and was
interpreted using the Cα backbone of the published structure of UMP
kinase from yeast as a template [5]. The central parallel β strands and
some homologous α helices were first visually adjusted in the map.
Other parts were constructed ab initio in the density calculated from a
combination of the SIRAS phases and the model phases (SFALL and
SIGMAA programs of the CCP4 suite [29]). Resolution was progres-
sively increased up to 1.92 Å in the refinement with the native 1 data
set, and only the grouped B factors (two for each residue) were
refined. Simulated annealing was also used a few times. Further refine-
ment included the individual B factors. Later on, using synchrotron data
(native 2), the structure was refined to a higher resolution of 1.75 Å.
Finally, we placed water molecules in residual density of more than
three standard deviations, according to electrostatic and geometric
considerations. Solvent molecules having B factors higher than 70 Å2
after refinement were discarded. The final model of the CMPKeco apo-
enzyme contains residues 3–179 and 193–227.
For the CMPKeco–CDP complex, the final model contains residues
3–223. The solution from AMoRe gave a clear electron-density map
inside which the initial model fitted well, except for two regions:
Ala38–Leu45 (the border of the NMPbind domain of CMPKeco) and
Ser150–Asn170 (involved in the LID movement). These regions and
the Glu180–Pro192 region, which was disordered in apo CMPKeco,
were manually constructed. The CDP model was constructed only in
the final steps of refinement, after its density became obvious as a con-
sequence of the construction of the Glu180–Pro192 region.
A summary of the refinement results together with model statistics are
given in Table 3. The Ramachandran plot indicates that both models
have around 90% or more residues in the most favored regions (as
defined by PROCHECK [34]).
Accession numbers
The atomic coordinates of the apo CMPKeco and the CDP–CMPKeco
structures have been deposited in the Brookhaven Protein Data Bank
[35] with accession numbers 1cke and 2cmk, respectively.
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Table 3
Refinement statistics.
Apo CMPKeco* CDP–CMPKeco
Resolution range (Å) 7.0–1.75 7.0–2.0
R factor† (%) 20.5 21.3 
R free‡ (%) 25.9 22.0
Rms deviations
bond lengths (Å) 0.018 0.012
bond angles (°) 2.46 2.96
Average B factors (Å2)
mainchain 28.1 32.2
sidechain 36.6 39.8
nucleotide – 37.6
solvent 48.4 43.2 
sulfate S1 29.4 26.1
Nonhydrogen atoms used in refinement
protein 1616 1700
nucleotide – 25
solvent 156 106
Ramachandran statistics§
most favored regions (%) 94.1 89.9
additional allowed regions (%) 4.3 9.6
*Refinement calculations were based on the native 2 data set.
†R factor = Σ||Fobs|–|Fcalc||/ΣFobs, where |Fobs| and |Fcalc| are the
observed and calculated structure-factor amplitudes, respectively.
‡R free is the same as the R factor, but calculated with a 10% subset
of all reflections that were not used in the crystallographic refinement.
§As evaluated using the program PROCHECK [34].
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